Riskpilot← Back to searchSign inGet full accessPHARMA-TECH A/S
A/SActiveCVR 32940897Messingvej 23Manufacture of plastic packing goods · NACE 2222Est. 201040 employees
Revenue 2025
DKK 32,2M
+16% vs 2024
EBITDA margin
40.3%
0% vs 2024
Equity ratio
53.3%
Financial strength
Net profit 2025
DKK 5,6M
-15% vs 2024
| Revenue | DKK 32,2M | +16% |
| EBITDA | DKK 13M | +0% |
| Net profit | DKK 5,6M | -15% |
| Total assets | DKK 45,9M | +0% |
| Equity | DKK 24,5M | +7% |
| Employees | 40 | — |
Legal name
PHARMA-TECH A/S
CVR number
32940897
Legal form
Aktieselskab
NACE code
2222 · Manufacture of plastic packing goods
Founded
28. maj 2010
Share capital
DKK 500.000
Employees
40 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af tre bestyrelsesmedlemmer i forening eller den samlede bestyrelse i forening.
Company purpose
Selskabets formål er at drive handel og produktion og andre hermed beslægtede aktiviteter
Address
Messingvej 23
Phone
+4586481166
Email
mail@pharma-tech.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.373 | 10.200 | 11.197 | 12.479 | 11.737 | 13.256 | 14.661 | 15.288 | 28.973 | 18.038 | 19.333 | 24.107 | 27.739 | 32.243 |
| Staff expenses | -2.696 | -5.493 | -5.857 | -7.974 | -6.786 | -7.531 | -8.615 | -8.827 | -10.680 | -10.810 | -10.439 | -12.020 | -14.166 | -19.245 |
| EBITDA | 2.677 | 4.280 | 5.333 | 4.505 | 4.881 | 5.725 | 6.046 | 6.460 | 18.293 | 7.209 | 8.894 | 12.087 | 12.946 | 12.999 |
| Depreciation & amort. | -454 | -1.504 | 1.139 | 1.138 | 1.232 | -1.282 | -1.232 | -1.692 | -2.936 | -3.049 | -3.132 | -3.521 | -3.822 | -5.149 |
| EBIT | 2.224 | 2.776 | 4.194 | 3.367 | 3.649 | 4.444 | 4.814 | 4.769 | 15.357 | 4.161 | 5.762 | 8.566 | 9.124 | 7.850 |
| Net financials | -245 | -322 | -281 | -63 | -57 | -61 | -100 | -259 | -138 | -172 | -197 | -287 | -637 | -768 |
| Profit before tax | 1.979 | 2.454 | 3.913 | 3.304 | 3.593 | 4.383 | 4.714 | 4.510 | 15.219 | 3.989 | 5.564 | 8.279 | 8.486 | 7.082 |
| Tax | 487 | 719 | 1.050 | 853 | 861 | 1.017 | 1.042 | 1.004 | 3.351 | 878 | 1.228 | 1.826 | 1.887 | 1.445 |
| Net profit | 1.492 | 1.735 | 2.864 | 2.451 | 2.731 | 3.367 | 3.672 | 3.506 | 11.868 | 3.111 | 4.336 | 6.453 | 6.599 | 5.637 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5.599 | 10.953 | 12.310 | 12.144 | 14.075 | 14.694 | 17.872 | 21.341 | 30.519 | 28.660 | 29.471 | 40.568 | 45.875 | 45.922 |
| Equity | 2.626 | 4.362 | 7.225 | 5.677 | 6.908 | 8.275 | 8.946 | 10.452 | 22.320 | 17.431 | 19.767 | 24.220 | 22.820 | 24.457 |
| Long-term debt | 687 | 279 | 0 | 0 | 1.813 | 1.555 | 2.342 | 4.226 | 1.965 | 1.441 | 3.522 | 6.703 | 9.120 | 11.979 |
| Short-term debt | 2.245 | 6.279 | 5.022 | 6.412 | 5.240 | 4.666 | 6.333 | 6.624 | 6.099 | 9.521 | 5.936 | 9.460 | 13.821 | 9.379 |
| Total debt | 2.931 | 6.559 | 5.022 | 6.412 | 7.053 | 6.221 | 8.675 | 10.850 | 8.064 | 10.962 | 9.458 | 16.163 | 22.941 | 21.357 |
EBITDA margin
40.3%
This company
15.8%
Market median
+155% vs market
20122025
Equity ratio
53.3%
This company
38.2%
Market median
+40% vs market
20122025
Return on equity
23.0%
This company
18.4%
Market median
+25% vs market
20122025
Net profit margin
17.5%
This company
8.1%
Market median
+116% vs market
20122025
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20122025
Debt / equity
0.88×
This company
0.62×
Market median
+42% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OR Management | Management | 2018 | — | — |
HV Founder | Founder | 2010 | — | — |
MH Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2011 | — | — | |
| Chairman | 2018 | — | — | |
OG | Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
RUBEK HOLDING ApS | Company | 50.0% | 50.0% | 2015 |
JoWin Holding ApS | Company | 50.0% | 50.0% | 2015 |
HP-TRADING ApS | Company | 50.0% | 50.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
RUBEK HOLDING ApS
PHARMA-TECH A/S Board members of PHARMA-TECH A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Rubek | Management | 0 companies |
| Henrik Vinding Petersen | Founder | 0 companies |
| Morten Hart Johansen | Chief Executive Officer | 0 companies |
| Karina Rubek | Board of Directors | 0 companies |
| Peter Werner Fugmann | Board of Directors | 0 companies |
| Rikke Winther | Board of Directors | 0 companies |
| Carsten Hans Christoffersen | Board of Directors | 0 companies |
| Heinrich Legaard Küsch | Chairman | 0 companies |
| Claus Wædeled | Chairman | 0 companies |
| Ole Gade | Board of Directors | 0 companies |